Clinical trial
Determine the Effect of Administering Periostat(R) Twice Daily on Patients With…
NCT00041977 · CollaGenex Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00041977 |
|---|---|
| Title | Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Determine the Effects of Doxycycline Hyclate 20 Mg Tablets [Periostat(R)] Administered Twice Daily for the Treatment of Acne Rosacea |
| Lead sponsor | CollaGenex Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acne Rosacea |
| Intervention type | Drug |
| Interventions | doxycycline hyclate 20 mg twice daily |
| Enrollment | 150 |
| Start date | Jun 1, 2002 |
| First posted | Jul 23, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: